_version_ 1783490163601571840
author Kanlikilicer, Pinar
Bayraktar, Recep
Denizli, Merve
Rashed, Mohammed H.
Ivan, Cristina
Aslan, Burcu
Mitra, Rahul
Karagoz, Kubra
Bayraktar, Emine
Zhang, Xinna
Rodriguez-Aguayo, Cristian
El-Arabey, Amr Ahmed
Kahraman, Nermin
Baydogan, Seyda
Ozkayar, Ozgur
Gatza, Michael L.
Ozpolat, Bulent
Calin, George A.
Sood, Anil K.
Lopez-Berestein, Gabriel
author_facet Kanlikilicer, Pinar
Bayraktar, Recep
Denizli, Merve
Rashed, Mohammed H.
Ivan, Cristina
Aslan, Burcu
Mitra, Rahul
Karagoz, Kubra
Bayraktar, Emine
Zhang, Xinna
Rodriguez-Aguayo, Cristian
El-Arabey, Amr Ahmed
Kahraman, Nermin
Baydogan, Seyda
Ozkayar, Ozgur
Gatza, Michael L.
Ozpolat, Bulent
Calin, George A.
Sood, Anil K.
Lopez-Berestein, Gabriel
author_sort Kanlikilicer, Pinar
collection PubMed
description
format Online
Article
Text
id pubmed-6974767
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69747672020-01-28 Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112] Kanlikilicer, Pinar Bayraktar, Recep Denizli, Merve Rashed, Mohammed H. Ivan, Cristina Aslan, Burcu Mitra, Rahul Karagoz, Kubra Bayraktar, Emine Zhang, Xinna Rodriguez-Aguayo, Cristian El-Arabey, Amr Ahmed Kahraman, Nermin Baydogan, Seyda Ozkayar, Ozgur Gatza, Michael L. Ozpolat, Bulent Calin, George A. Sood, Anil K. Lopez-Berestein, Gabriel EBioMedicine Corrigendum Elsevier 2020-01-20 /pmc/articles/PMC6974767/ /pubmed/31972470 http://dx.doi.org/10.1016/j.ebiom.2020.102630 Text en © 2020 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Kanlikilicer, Pinar
Bayraktar, Recep
Denizli, Merve
Rashed, Mohammed H.
Ivan, Cristina
Aslan, Burcu
Mitra, Rahul
Karagoz, Kubra
Bayraktar, Emine
Zhang, Xinna
Rodriguez-Aguayo, Cristian
El-Arabey, Amr Ahmed
Kahraman, Nermin
Baydogan, Seyda
Ozkayar, Ozgur
Gatza, Michael L.
Ozpolat, Bulent
Calin, George A.
Sood, Anil K.
Lopez-Berestein, Gabriel
Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
title Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
title_full Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
title_fullStr Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
title_full_unstemmed Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
title_short Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
title_sort corrigendum to ‘exosomal mirna confers chemo resistance via targeting cav1/p-gp/m2-type macrophage axis in ovarian cancer’ [ebiomedicine 38 (2018) 100–112]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974767/
https://www.ncbi.nlm.nih.gov/pubmed/31972470
http://dx.doi.org/10.1016/j.ebiom.2020.102630
work_keys_str_mv AT kanlikilicerpinar corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT bayraktarrecep corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT denizlimerve corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT rashedmohammedh corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT ivancristina corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT aslanburcu corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT mitrarahul corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT karagozkubra corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT bayraktaremine corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT zhangxinna corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT rodriguezaguayocristian corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT elarabeyamrahmed corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT kahramannermin corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT baydoganseyda corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT ozkayarozgur corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT gatzamichaell corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT ozpolatbulent corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT calingeorgea corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT soodanilk corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112
AT lopezberesteingabriel corrigendumtoexosomalmirnaconferschemoresistanceviatargetingcav1pgpm2typemacrophageaxisinovariancancerebiomedicine382018100112